KPCM
BSX icon

Kings Point Capital Management’s Boston Scientific BSX Stock Holding History

Kings Point Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-500
Closed -$12K – 335
2017
Q1 		$12K Buy
+500
New +$12.2K ﹤0.01% 331

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Kings Point Capital Management's BSX Position: Q2 2017 in Review

Kings Point Capital Management sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 500 shares — an estimated $12K sold.

Kings Point Capital Management first reported a position in BSX in Q1 2017 and held it in 1 quarter. The position peaked at $12K in Q1 2017. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Kings Point Capital Management reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
  • Kings Point Capital Management sold 500 Boston Scientific shares in Q2 2017, an estimated $12K.
  • Kings Point Capital Management first reported a position in Boston Scientific in Q1 2017 and held it in 1 quarter.
  • Kings Point Capital Management's Boston Scientific position peaked at $12K in Q1 2017.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Kings Point Capital Management's 13F filing for Q2 2017, filed 8 Aug 2017.